Loperamide and Brain Cancer: A 2021 Lab Study, Fact Check

An Instagram post from @hashem.alghaili, posted around October 30, 2026, says: "An anti-diarrhea drug can kill aggressive brain cancer cells, new research reveals." The post names loperamide (Imodium) and cites a paper in the journal Autophagy. It also says this does not mean loperamide can cure brain cancer.

View the original post

What's real

The paper exists. It is "ATF4 links ER stress with reticulophagy in glioblastoma cells," by Svenja Zielke and colleagues, in Autophagy 2021, volume 17, issue 9, pages 2432-2448. Researchers at Goethe University Frankfurt in Germany worked on it. Nina Meyer is one of 12 authors, not the first author.

The authors found that loperamide caused a type of cell death in a glioblastoma cell line. They traced part of the process to ATF4, a protein switched on by cell stress, and to "reticulophagy," the cell's breakdown of parts of its own endoplasmic reticulum (ER). When the researchers knocked out ATF4, loperamide caused less of this breakdown and less cell death. The post describes this part correctly.

What's missing or wrong

"New research" is not right. PubMed lists the paper as published online October 28, 2020, and in print in September 2021. The online date is six years before the post, and the print date is five years before it.

The headline leaves out "in lab-grown cells." According to the paper's full text, the cell death experiments used a human glioblastoma cell line called MZ-54, grown in dishes. We found no animal or patient work described in the paper. Goethe University's own news release says the same: the findings come from cell experiments.

The dose in the dish is not a dose for a person. Most experiments used loperamide at 17.5 micromolar, and the cell-death test ran for 48 hours. The paper does not say whether a person could safely reach that level in the brain, and we did not find a source that says so.

Loperamide may not reach the brain. The university's release says researchers have not yet worked out how loperamide could cross the blood-brain barrier. It notes that nanoparticles are one possible approach. The post mentions this barrier too.

"Aggressive cancer cells" is not the whole picture. In the same paper, loperamide triggered autophagy but not cell death in mouse embryonic fibroblasts, which are not cancer cells. The authors also say the process upstream of ATF4 is still unresolved. They write that it "cannot be completely excluded" that loperamide simply causes a general, bulk form of autophagy.

What the study did, and what FDA warns

What it shows. In one glioblastoma cell line, loperamide set off a stress response and cell death, and ATF4 was needed for part of it. That is a clue about how cells die. It is an early step.

What it does not show. It does not show that loperamide shrinks a tumor in an animal or a person. Goethe University's release says further studies are necessary before loperamide could be used for glioblastoma or other diseases. A process that kills cells in a dish often fails in animals or people. For how to read this kind of result, see Clinical Trial Results: What They Mean.

Safety. The FDA says loperamide is safe at approved doses. The most it approves for adults is 8 mg a day for over-the-counter use and 16 mg a day on prescription. FDA first warned about this on June 7, 2016. In a January 30, 2018 update, it said it kept receiving reports of serious heart problems and deaths at much higher than recommended doses, mostly among people misusing the drug. Those problems include severe heart rhythm problems, QT interval prolongation, fainting and cardiac arrest. The paper did not test any dose in people.

What to do with this

Do not take extra loperamide to treat cancer. Taking more than the label or your team says can cause dangerous heart rhythm problems. It will not treat a brain tumor. If you want to ask about this research, ask your neuro-oncology team. If you have diarrhea during treatment, follow your care team's directions on what to take and when to call. Our guide to diarrhea during cancer treatment explains the usual steps. FDA also says to stop over-the-counter loperamide and call your health care professional if diarrhea lasts more than 2 days.

Call 911 if you or someone taking loperamide faints, has a rapid or irregular heartbeat, or cannot be woken up. Tell the responders about the loperamide.

If you have a fever of 100.4 F (38 C) or higher during cancer treatment, call your care team right away. For emergencies, call 911.

To learn what is known about the disease, see our guide to glioblastoma. To check other viral claims, see how to recognize cancer misinformation online.

Sources

• Instagram post (@hashem.alghaili): instagram.com
• Zielke S, et al., "ATF4 links ER stress with reticulophagy in glioblastoma cells," Autophagy 2021 (PubMed record): pubmed.ncbi.nlm.nih.gov
• Same paper, free full text: pmc.ncbi.nlm.nih.gov
• Goethe University Frankfurt news release, December 21, 2020, as posted on EurekAlert: eurekalert.org
• FDA, "FDA limits packaging for anti-diarrhea medicine loperamide (Imodium) to encourage safe use," January 30, 2018, an update to the June 7, 2016 Drug Safety Communication: fda.gov
• National Cancer Institute, "Complementary and Alternative Medicine": cancer.gov

How this article was prepared

An AI-assisted editorial system helped prepare this page. It used the paper's PubMed record and full text, a university news release, and an FDA safety communication that we opened on October 31, 2026. The original June 2016 FDA page did not open (404), so we relied on the 2018 update, which restates it. The press release we read did not itself mention a high-dose warning; the heart rhythm warning comes from FDA. No named medical reviewer has reviewed it unless one is listed.

Cancer Explained is published by the National Cancer Information Foundation. It is not medical advice and does not suggest a test or treatment.

See an error, old source, or unclear wording? Tell us.